Top Back to top

The EBMT comments on the Guidelines on Good Clinical Practice for ATMPs

by Eoin McGrath

The EBMT responded to the public consultation by the European Commission "Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products".

The comments received from all contributors will be taken into account by the EU Commission in the finalisation of the Guidelines on Good Clinical Practice specific to Advanced Therapy Medicinal Products.

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to